Fedratinib is a selective inhibitor of JAK2.Fedratinib has potential antineoplastic activity. Fedratinib inhibits proliferation and induces apoptosis.
This report contains market size and forecasts of Fedratinib in global, including the following market information:
Global Fedratinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fedratinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Fedratinib companies in 2021 (%)
The global Fedratinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fedratinib include Santa Cruz Biotechnology, Cayman Chemical, Adooq Bioscience, BioVision, APExBIO Technology, Selleck Chemicals, AbMole, BOC Sciences and TargetMol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fedratinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fedratinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fedratinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Fedratinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fedratinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Fedratinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fedratinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fedratinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fedratinib revenues share in global market, 2021 (%)
Key companies Fedratinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Fedratinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santa Cruz Biotechnology
Cayman Chemical
Adooq Bioscience
BioVision
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
MyBiosource
Aladdin
LifeSpan BioSciences
Taiclone